Chemsex in HIV pre‐exposure prophylaxis users: Assessment of mood disorders and addictive behavior.

Autor: Peyriere, Hélène, Jacquet, Jean‐Marc, Peries, Marianne, Tribout, Vincent, Broche, Béatrice, Mauboussin, Jean‐Marc, Makinson, Alain, Perrollaz, Cyril, Ferreyra, Milagros, Rouanet, Isabelle, Montoya‐Ferrer, Ana, El‐Majjaoui, Said, Corriol‐Bonifas, Florence, Fraisse, Thibaut, Grau, Fanny, Laureillard, Didier, Nagot, Nicolas, Reynes, Jacques, Donnadieu‐Rigole, Hélène

Publikováno v: Fundamental & Clinical Pharmacology; Jun2023, Vol. 37 Issue 3, p639-649, 11p

Factores clínicos y biológicos asociados a la infección por el virus de Epstein-Barr en niños expuestos no infectados al Virus de la Inmunodeficiencia Humana

Autor: Montoya Ferrer, Ana

Publikováno v: Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Biblos-e Archivo. Repositorio Institucional de la UAM
instname

Tesis doctoral inédita leída en la Universidad Autónoma de Madrid, Facultad de Medicina, Departamento de Medicina. Fecha de lectura: 22-02-2021
El número de niños expuestos pero no infectados por el virus de la inmunodeficiencia humana (HIV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::29a3e3fff53a441cbe55cfcb6f6c2f52
http://hdl.handle.net/10486/694963

Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen.

Autor: Palich, Romain, Allavena, Clotilde, Peytavin, Gilles, Soulie, Cathia, Tubiana, Roland, Weiss, Laurence, Ferrer, Ana Montoya, Duvivier, Claudine, Bouchaud, Olivier, Bottero, Julie, Durand, Aurore, Lê, Minh-Patrick, Marcelin, Anne-Geneviève, Dudoit, Yasmine, Assoumou, Lambert, Katlama, Christine, group, the ETRAL QD study, Montoya Ferrer, Ana, ETRAL QD study group

Publikováno v: Journal of Antimicrobial Chemotherapy (JAC); Feb2021, Vol. 76 Issue 2, p477-481, 5p

Clinical and Biological Factors Associated With Early Epstein-Barr Virus Infection in Human Immunodeficiency Virus-Exposed Uninfected Infants in Eastern Uganda.

Autor: Montoya-Ferrer A; Pathogenesis and Control of Chronic Infections, Institut national de la santé et de la recherche médicale (INSERM), Etablissement Français du Sang, University of Montpellier, Montpellier University Hospital CHU, Montpellier, Montpellier, France., Sanosyan A; Pathogenesis and Control of Chronic Infections, Institut national de la santé et de la recherche médicale (INSERM), Etablissement Français du Sang, University of Montpellier, Montpellier University Hospital CHU, Montpellier, Montpellier, France., Fayd'herbe de Maudave A; Pathogenesis and Control of Chronic Infections, Institut national de la santé et de la recherche médicale (INSERM), Etablissement Français du Sang, University of Montpellier, Montpellier University Hospital CHU, Montpellier, Montpellier, France., Pisoni A; Pathogenesis and Control of Chronic Infections, Institut national de la santé et de la recherche médicale (INSERM), Etablissement Français du Sang, University of Montpellier, Montpellier University Hospital CHU, Montpellier, Montpellier, France., Bollore K; Pathogenesis and Control of Chronic Infections, Institut national de la santé et de la recherche médicale (INSERM), Etablissement Français du Sang, University of Montpellier, Montpellier University Hospital CHU, Montpellier, Montpellier, France., Molès JP; Pathogenesis and Control of Chronic Infections, Institut national de la santé et de la recherche médicale (INSERM), Etablissement Français du Sang, University of Montpellier, Montpellier University Hospital CHU, Montpellier, Montpellier, France., Peries M; Pathogenesis and Control of Chronic Infections, Institut national de la santé et de la recherche médicale (INSERM), Etablissement Français du Sang, University of Montpellier, Montpellier University Hospital CHU, Montpellier, Montpellier, France., Tylleskar T; Center for International Health, University of Bergen, Bergen, Norway., Tumwine JK; Department of Pediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda., Ndeezi G; Department of Pediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda., Gorgolas M; Department of Infectious Diseases, Hospital Fundación Jiménez-Díaz, University Autonoma, Madrid, Spain., Nagot N; Pathogenesis and Control of Chronic Infections, Institut national de la santé et de la recherche médicale (INSERM), Etablissement Français du Sang, University of Montpellier, Montpellier University Hospital CHU, Montpellier, Montpellier, France., van de Perre P; Pathogenesis and Control of Chronic Infections, Institut national de la santé et de la recherche médicale (INSERM), Etablissement Français du Sang, University of Montpellier, Montpellier University Hospital CHU, Montpellier, Montpellier, France., Tuaillon E; Pathogenesis and Control of Chronic Infections, Institut national de la santé et de la recherche médicale (INSERM), Etablissement Français du Sang, University of Montpellier, Montpellier University Hospital CHU, Montpellier, Montpellier, France.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Mar 15; Vol. 72 (6), pp. 1026-1032.